A recent study by Chiu et al. showed that iPSC-derived NK cells engineered to express the activating memory NK cell receptor, NKG2C, demonstrated enhanced cytotoxicity against AML blasts [138]. The gene discussed is KLRD1; the disease is acute myeloid leukemia.